329 related articles for article (PubMed ID: 25621996)
21. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
[TBL] [Abstract][Full Text] [Related]
22. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
[TBL] [Abstract][Full Text] [Related]
23. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
[TBL] [Abstract][Full Text] [Related]
24. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
[TBL] [Abstract][Full Text] [Related]
25. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
26. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
Kim S; Youn H; Song MG; Kang JH; Chung HK; Lee DS; Chung JK
Cancer Gene Ther; 2012 Apr; 19(4):263-70. PubMed ID: 22301953
[TBL] [Abstract][Full Text] [Related]
27. Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
Klutz K; Willhauck MJ; Wunderlich N; Zach C; Anton M; Senekowitsch-Schmidtke R; Göke B; Spitzweg C
Hum Gene Ther; 2011 Nov; 22(11):1403-12. PubMed ID: 21488714
[TBL] [Abstract][Full Text] [Related]
28. Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (
Tutter M; Schug C; Schmohl KA; Urnauer S; Schwenk N; Petrini M; Lokerse WJM; Zach C; Ziegler S; Bartenstein P; Weber WA; Wagner E; Lindner LH; Nelson PJ; Spitzweg C
Theranostics; 2020; 10(10):4490-4506. PubMed ID: 32292510
[No Abstract] [Full Text] [Related]
29. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
30. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
[TBL] [Abstract][Full Text] [Related]
31. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
Zhang M; Guo R; Shi S; Miao Y; Zhang Y; Li B
PLoS One; 2014; 9(3):e92326. PubMed ID: 24647588
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
Schipper ML; Riese CGU; Seitz S; Weber A; Béhé M; Schurrat T; Schramm N; Keil B; Alfke H; Behr TM
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):638-650. PubMed ID: 17160413
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Hispidulin, a Flavonoid from
Dai Y; Sun X; Li B; Ma H; Wu P; Zhang Y; Zhu M; Li HM; Qin M; Wu CZ
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799348
[TBL] [Abstract][Full Text] [Related]
34. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
Willhauck MJ; Sharif Samani BR; Gildehaus FJ; Wolf I; Senekowitsch-Schmidtke R; Stark HJ; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2007 Nov; 92(11):4451-8. PubMed ID: 17698909
[TBL] [Abstract][Full Text] [Related]
35. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
[TBL] [Abstract][Full Text] [Related]
37. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
38. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
[TBL] [Abstract][Full Text] [Related]
40. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
Kim HJ; Jeon YH; Kang JH; Lee YJ; Kim KI; Chung HK; Jeong JM; Lee DS; Lee MC; Chung JK
Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
